Skip to content

Clinical trials

Schizophrenia trials in the Philippines

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Country / region: Philippines Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20043
20085
20092
20103
20113
20121
20133
20141
20191
20212
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21
Terminated4
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Otsuka Pharmaceutical Development & Commercialization, Inc.8
Alkermes, Inc.3
AstraZeneca3
Sumitomo Pharma America, Inc.3
Boehringer Ingelheim2
H. Lundbeck A/S2
Sumitomo Pharma Co., Ltd.2
Janssen Research & Development, LLC1
Otsuka Pharmaceutical, Inc., Philippines1
Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia26
Autistic Disorder1
Bipolar Disorder1
Disease1
Major Depressive Disorder1
Mania1
Recurrence1

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.